These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 31799)
1. Endocrine testing in tardive dyskinesias: preliminary report. Rosenbaum AH; Maruta T; Jiang NS; Auger RG; de la Fuente JR; Duane DD Am J Psychiatry; 1979 Jan; 136(1):102-3. PubMed ID: 31799 [No Abstract] [Full Text] [Related]
2. A study of state-dependent reversal of tardive dyskinesia: phenomenological probe in humans. Goswami U; Narayanan HS; Channabasavanna SM J Clin Psychopharmacol; 1985 Feb; 5(1):48-50. PubMed ID: 2857733 [TBL] [Abstract][Full Text] [Related]
3. Lithium intraerythrocyte levels in tardive dyskinesia: a preliminary report. Yassa R; Schwartz G; Wood P Biol Psychiatry; 1983 Jul; 18(7):825-8. PubMed ID: 6137247 [No Abstract] [Full Text] [Related]
4. Depression as a predictor in the development of tardive dyskinesia. Yassa R; Schwartz G Biol Psychiatry; 1984 Mar; 19(3):441-4. PubMed ID: 6144331 [No Abstract] [Full Text] [Related]
17. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. Shriqui CL; Bradwejn J; Annable L; Jones BD Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951 [TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia. Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis. Wolf ME; DeWolfe AS; Mosnaim AD Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712 [TBL] [Abstract][Full Text] [Related]